Koru announces pact for next-gen subcutaneous immunoglobulin infusion system
Systems announced the signing of an agreement with a global pharmaceutical company. The agreement is intended for KORU ...
FDA approves wearable infusion device for advanced Parkinson disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...